Announcement on Progress in Retrial of Significant Litigation Matters
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Progress in Retrial of Significant Litigation Matters
Filed with SSE · · 8 pages · Chinese
Release
HPGC Renmintongtai Pharmaceutical Corporation on 6ix
Earlier from HPGC Renmintongtai Pharmaceutical
- Report for Q3 2024
- Announcement on Convening the 2024 Semi-annual Performance Briefing
- Semi-annual Report in 2024
- Announcement on Implementation of Dividend Distribution for 2023
- Announcement on Resolutions of 2023 Annual General Meeting
Later from HPGC Renmintongtai Pharmaceutical
- Announcement on Implementing the "Corporate Value and Return Enhancement" Action Plan
- Announcement on the Resignation and Appointment of General Manager
- Announcement on Resolution of the 18th Meeting of the 10th Board of Directors
- Report for Q1 2025
- Announcement on Convening the 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing
Follow HPGC Renmintongtai Pharmaceutical into a list and get an email when it puts out news.
Follow HPGC Renmintongtai Pharmaceutical